ARVIND REMEDIES LIMITED  
    UNAUDITED FINANCIAL RESULTS  
    FOR THE THREE MONTHS AND HALF YEAR ENDED SEPTEMBER 30, 2007  
                (Rupees in Lakhs.)    
      Particulars Three months ended 30.09.2007 Three months ended 30.09.2006 Corresponding six months ended 30.09.2007 Corresponding six months ended 30.09.2006 Year ended 31.3.2007    
        Unaudited Unaudited Unaudited Unaudited Audited    
      Gross Sales   4963.45 4196.73               9,559.25                8,588.68               17,972.93        
      Less: Excise Duty                   (622.88)                (618.19)             (1,171.46)              (1,092.27)               (2,314.43)        
      Net Sales                  4,340.57               3,578.54               8,387.79                7,496.41               15,658.50        
      Other Income 6.33 8.69                      8.91                     11.47                      21.58        
      Total Income                  4,346.90               3,587.23               8,396.70                7,507.88               15,680.08        
                         
      Expenditure :                  
      a)  (Increase) / Decrease in Stock                     168.86                  (52.51)                  (86.76)                   100.88                  (300.68)        
      b)  Consumption of raw materials 3646.06               3,173.70               7,203.17                6,264.53               13,563.16    
      c)  Purchase of traded goods                            -                           -                      30.80                     30.90                      84.47    
      d)  Employee Cost 101.58 81.48                  194.10                   159.74                    340.42      
      e)  Depreciation 44.35 41.74                    87.99                     82.95                    170.12      
      f)  Other expenditure 118.87 119.33                  249.41                   231.89                    618.13      
      Total (a) to (f)                  4,079.72               3,363.74               7,678.71                6,870.89               14,475.62        
      Interest 164.75 133.28                  328.12                   267.53                    655.18        
      Exceptional Items                            -                           -                           -                            -                             -          
      Profit from ordinary activities before tax                     102.43                    90.21                  389.87                   369.46                    549.28        
      Provision for Taxation                  
           Income Tax (Including Fringe Benefit Tax)                       13.27                    20.00                    40.00                     40.00                      85.86        
           Earlier years                            -                        0.12                         -                         0.12                    (31.48)        
           Deferred Tax                     (10.76)                  (11.08)                  (23.48)                   (21.11)                      56.13        
           Wealth Tax                            -                           -                              0.29        
      Profit from ordinary activities after tax                       99.92                    81.17                  373.35                   350.45                    438.48        
      Extraordinary Items (net of tax expense)                            -                            -                            -                            -                              -          
      Net profit for the period                       99.92                    81.17                  373.35                   350.45                    438.48        
                         
      Paid-up Equity Share Capital 2600.50 2600.50 2600.50 2600.50 2600.50        
      (face value Re. 1/- per Share)                  
      Reserves excluding Revaluation Reserve                            -                           -                           -                            -                   1,521.31        
      Basic and Diluted Earnings Per Share before and after extraordinary items (Rs.)                         0.04                      0.03                      0.14                       0.13                        0.17        
      Public Shareholding                  
         Number of shares 194205340 194205340 194205340 194205340 194205340        
         Percentage of Shareholding 74.68% 74.68% 74.68% 74.68% 74.68%        
             
      Notes :        
      1. The Company operates only in one business segment namely  formulations.      
      2. Previous period's figures have been regrouped / rearranged  wherever necessary to confirm to the current periods classification.      
      3. The revised Accounting Standard 15 "Employee Benefits" issued by the Institute of Chartered Accountants of India has become applicable to the Company with effect    
          from April 1, 2007.  The impact of such revision, which is not likely to be material, will be considered at the year end.      
      4. Provision for taxation for the six months ended September 30, 2007 has been made on an estimate basis.  The actual tax liability will be determined on the basis of     
          the taxable income of the Company for the year from April 1, 2007 to March 31, 2008.      
      5. The above results were reviewed by the audit committee and taken on record at the meeting of the Board of Directors held on November 30, 2007.      
      6. During the quarter nil investor complaints were received and disposed off.  There were no investor complaints pending for the redressal as at the       
          the commencement and end of the quarter.        
      7. The above results  have been subjected to a Limited Review by the statutory auditors as per the listing agreement with the stock exchanges.      
             
             
      Chennai - 600 084     For ARVIND REMEDIES LTD.    
      Date: November 30, 2007      
           
            Dr. Chandra Ravindran    
            Director